Chemoinformaics analysis of 2,2-Dimethyltetradecane
| Molecular Weight | 226.448 | nRot | 10 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 0 |
| Exact Molecular Weight | 226.266 | nRing | 0 |
| Solubility: LogS | -7.076 | nHRing | 0 |
| Solubility: LogP | 8.187 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 49.391 |
| nHD | 0 | BPOL | 34.109 |
| QED | 0.381 |
| Synth | 1.793 |
| Natural Product Likeliness | 0.149 |
| NR-PPAR-gamma | 0.043 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.626 |
| MDCK | 0.00000583 |
| BBB | 0.27 |
| PPB | 0.9913 |
| VDSS | 3.89 |
| FU | 0.0225 |
| CYP1A2-inh | 0.189 |
| CYP1A2-sub | 0.291 |
| CYP2c19-inh | 0.492 |
| CYP2c19-sub | 0.346 |
| CYP2c9-inh | 0.132 |
| CYP2c9-sub | 0.966 |
| CYP2d6-inh | 0.09 |
| CYP2d6-sub | 0.096 |
| CYP3a4-inh | 0.291 |
| CYP3a4-sub | 0.09 |
| CL | 4.513 |
| T12 | 0.084 |
| hERG | 0.153 |
| Ames | 0.007 |
| ROA | 0.04 |
| SkinSen | 0.935 |
| Carcinogencity | 0.031 |
| EI | 0.934 |
| Respiratory | 0.54 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.603749 |